The long-term course of cyclosporine-associated chronic nephropathy

B D Myers1, R Sibley, L Newton

  • 1Department of Medicine, Stanford University Medical Center, California.

Kidney International
|February 1, 1988
PubMed

Insights

Cyclosporine (CsA) therapy in heart transplant patients causes chronic kidney injury, leading to reduced kidney function and progressive renal damage. This injury to renal microvessels is often irreversible.

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Cardiovascular Medicine

Background:

  • Cyclosporine (CsA) is a key immunosuppressant in organ transplantation.
  • Chronic kidney injury is a significant concern in long-term transplant recipients.
  • The specific renal effects of CsA in cardiac transplant recipients require detailed evaluation.

Purpose of the Study:

  • To assess the incidence and nature of chronic renal injury in cardiac transplant recipients treated with CsA.
  • To compare renal function and pathology in CsA-treated patients versus azathioprine-treated controls.
  • To investigate the reversibility and progression of CsA-induced nephropathy.

Main Methods:

  • Evaluation of 37 cardiac transplant recipients on CsA (12-24 months) and 24 controls on azathioprine (>24 months).
  • Assessment of glomerular filtration rate (GFR), renal vascular resistance (RVR), proteinuria, and blood pressure.
  • Histopathological examination of renal biopsies, including arteriolopathy, tubulointerstitial damage, and glomerular changes.
  • Longitudinal follow-up over 48 months with dosage adjustments and repeat biopsies in a subset of patients.

Main Results:

  • CsA-treated patients showed significantly depressed GFR (47 vs 94 ml/min/1.73 m2) compared to controls.
  • CsA therapy was associated with elevated RVR, proteinuria, hypertension, and impaired renin activity.
  • Histopathology revealed obliterative arteriolopathy, tubulointerstitial damage, glomerular changes, and mesangial expansion.
  • Longitudinal data indicated persistent hypofiltration, increased RVR, and worsening proteinuria even after CsA reduction or withdrawal.
  • Three patients developed end-stage renal disease, and further histopathological deterioration was observed.

Conclusions:

  • Continuous CsA therapy for over 12 months induces chronic, rarely reversible, and potentially progressive injury to renal microvessels.
  • CsA-associated nephropathy involves vascular, interstitial, and glomerular damage.
  • Early identification and management strategies are crucial to mitigate long-term renal consequences in CsA-treated patients.

Related Concept Videos

Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma happens...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...